Scribd Logo
Upload

Welcome to Scribd!

  • 54 views

    CB - Concept of Advertising

    Uploaded by

    PRIYA RATHORE
    This document discusses pharmaceutical advertising and FDA regulations surrounding it. It begins by defining pharmaceutical marketing as activities focused on making physicians and the public aware of brand name and existing drugs. It notes that drug advertising was legalized in 1985 by an FDA ruling. The FDA has since enacted several regulations to protect consumers while allowing advertising. The regulations require ads to provide generic drug alternatives, list only FDA-approved uses, note common side effects and how to report them, and require truth in claims and pricing.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd

    CB - Concept of Advertising

    Uploaded by

    PRIYA RATHORE
    54 views8 pages
    This document discusses pharmaceutical advertising and FDA regulations surrounding it. It begins by defining pharmaceutical marketing as activities focused on making physicians and the public aware of brand name and existing drugs. It notes that drug advertising was legalized in 1985 by an FDA ruling. The FDA has since enacted several regulations to protect consumers while allowing advertising. The regulations require ads to provide generic drug alternatives, list only FDA-approved uses, note common side effects and how to report them, and require truth in claims and pricing.

    Original Title

    CB- Concept of Advertising

    Copyright

    © © All Rights Reserved

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document discusses pharmaceutical advertising and FDA regulations surrounding it. It begins by defining pharmaceutical marketing as activities focused on making physicians and the public aware of brand name and existing drugs. It notes that drug advertising was legalized in 1985 by an FDA ruling. The FDA has since enacted several regulations to protect consumers while allowing advertising. The regulations require ads to provide generic drug alternatives, list only FDA-approved uses, note common side effects and how to report them, and require truth in claims and pricing.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    54 views8 pages

    CB - Concept of Advertising

    Uploaded by

    PRIYA RATHORE
    This document discusses pharmaceutical advertising and FDA regulations surrounding it. It begins by defining pharmaceutical marketing as activities focused on making physicians and the public aware of brand name and existing drugs. It notes that drug advertising was legalized in 1985 by an FDA ruling. The FDA has since enacted several regulations to protect consumers while allowing advertising. The regulations require ads to provide generic drug alternatives, list only FDA-approved uses, note common side effects and how to report them, and require truth in claims and pricing.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    of 8

    “CONCEPT OF

    ADVERTISING”

    SUBMITTED TO:
    Dr. Jaseela Majeed
    SUBMITTED BY:
    Priya Rathore
    Pharm MBA, 3rd sem
    “Advertising”
    “ Pharmaceutical Advertising”

    • The definition of pharmaceutical marketing is


    activities focused on making physicians as
    well as the general public aware of new and
    existing pharmaceutical brands.
    Advertising in the
    Pharmaceutical Industry
    • Pharmaceutical companies weren't able to
    advertise their products until the U.S. Food and
    Drug Administration ruling made the process
    legal in 1985.

    • Proponents argue drug advertising helps to


    educate consumers and may encourage them to
    talk to their doctors about medication options.
    Opponents argue that it may mislead consumers.

    • The FDA has enacted several pharmaceutical


    marketing regulations in an effort to protect
    consumers while allowing advertising to
    continue.
    Contd.
    1. By the Rules
    • FDA regulations for pharmaceutical advertisements apply primarily to prescription medications. However,
    the agency does not control ads for over-the-counter drugs. Dietary supplement and vitamin ads don't
    have to be approved and therefore aren't subject to most FDA regulations. Supplement manufacturers
    still have to caution consumers that statements and claims regarding their products have not been
    evaluated by the agency.

    2. Alternative Products
    • Pharmaceutical ads must provide the generic equivalent of name-brand drugs so consumers can pursue
    cost-saving options. Companies are not, however, required to directly state that a generic version of their
    drug is available. For example, an ad for name-brand drug Vyvanse, a treatment for Attention Deficit
    Hyperactivity Disorder, might at some point state that "Lisdexamfetamine dimesylate has been shown
    to..." as a way of incorporating the generic name without recommending it.
    Contd.
    3. Approved Uses
    • Pharmaceutical advertisements can't hint that a drug will improve a consumer's life. Instead, they
    have to list at least one use for which the drug is FDA approved. Drug makers also can't recommend
    that their product be used for off-label or unapproved uses. Even hinting at them could be a violation
    of the law.

    4. Side Effects
    • While pharmaceutical companies must note common side effects as well as how consumers can
    report these effects in their ads, there's no law against marketing drugs with serious side effects.
    Additionally, prescription drug companies have to include a leaflet with their drugs that clearly
    communicates all clinically verified risks of the medication.
    Contd.
    5. Truth in Advertising
    • All pharmaceutical advertisements must be truthful. They can't imply that a product does something
    it does not or give misleading statistics on its effectiveness. They're also prohibited from using
    misleading pricing tactics. For example, an ad can't say that Medicaid will cover the drug when
    Medicaid may or may not do so. All advertisers -- pharmaceutical or otherwise -- are prohibited from
    using bait-and-switch pricing gimmicks, which draw buyers in with a lower price and then encourage
    them to purchase a higher-priced item instead.
    THANK YOU

    You might also like